Congress Wealth Management LLC DE increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 45,073 shares of the medical equipment provider’s stock after buying an additional 656 shares during the period. Congress Wealth Management LLC DE’s holdings in Intuitive Surgical were worth $23,527,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Dillon & Associates Inc. lifted its holdings in Intuitive Surgical by 2.3% during the 4th quarter. Dillon & Associates Inc. now owns 24,823 shares of the medical equipment provider’s stock worth $12,958,000 after buying an additional 549 shares during the last quarter. Crowley Wealth Management Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $86,000. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the period. LPL Financial LLC raised its stake in Intuitive Surgical by 10.5% during the fourth quarter. LPL Financial LLC now owns 364,191 shares of the medical equipment provider’s stock worth $190,883,000 after acquiring an additional 34,487 shares during the period. Finally, Harbor Advisors LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $261,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on ISRG. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Robert W. Baird cut their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last three months. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Price Performance
Shares of ISRG opened at $492.49 on Monday. The company has a market capitalization of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average price is $562.24 and its 200 day moving average price is $532.03. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Bank Stocks – Best Bank Stocks to Invest In
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 ETFs to Ride the VIX Surge During Market Volatility
- How to Invest in Small Cap StocksĀ
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.